Journal of biomaterials science. Polymer edition·2015
Biodegradable polyhydroxyalkanoates serve as effective matrices for the antitumor drug daunorubicin (rubomycin). These drug delivery systems offer prolonged release kinetics, ideal for sustained therapeutic action.
Area of Science:
Biomaterials science
Polymer chemistry
Pharmacology
Context:
Developing novel drug delivery systems is crucial for improving therapeutic efficacy and patient compliance.
Biodegradable polymers offer a promising platform for controlled drug release applications.
Daunorubicin (rubomycin) is a potent anthracycline antibiotic used in cancer chemotherapy.
Purpose:
To investigate the potential of microbial polyhydroxyalkanoates as matrices for daunorubicin (rubomycin) deposition.
To characterize the in vitro release kinetics of daunorubicin from polyhydroxyalkanoate matrices.
To evaluate the feasibility of creating prolonged-action drug formulations.
Summary:
Tablets containing varying loads of daunorubicin (1-60% w/w) were prepared using cold compaction of polyhydroxyalkanoates.
In vitro studies demonstrated that daunorubicin release occurred through dissolution and diffusion.
Release profiles varied from tens of hours to several months, depending on drug loading.
At loads below 20% w/w, release was prolonged and time-dependent.
At concentrations below 5%, drug release followed zero-order kinetics with minimal initial burst release.
Impact:
Polyhydroxyalkanoates are suitable matrices for daunorubicin encapsulation.
This research enables the development of advanced drug delivery systems for sustained daunorubicin therapy.
The findings contribute to the field of biodegradable drug delivery, offering potential for improved cancer treatment strategies.